Tag: Cipla
Aurobindo Pharma to manufacture, supply long-acting HIV treatment drug
Hyderabad-based Aurobindo Pharma has been selected as one of the generic manufacturers under the expanded voluntary licensing agreement between the Medicines Patent Pool (MPP)...
US exempts Indian pharmaceuticals from reciprocal tariffs
In the recent progression of imposing tariffs, U.S. President Donald Trump has exempted Indian pharmaceutical products from the newly imposed reciprocal tariffs. This exemption...
Sanofi & Cipla to expand reach of CNS portfolio in India
Sanofi India and Cipla have announced an exclusive partnership for distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India....
Nasal spray market may grow to $16.85 billion by 2031
The Global Nasal Spray Market, valued at $9.21 billion in 2021, is projected to achieve significant growth, reaching $16.85 billion by 2031 at a...
25 years of AG Poly Packs: Trading to manufacturing to R&D
Established in the year 1997, AG Poly Packs is now in its 26th year of operations. It started with trading in rigid packaging for...
InnoPack Pharma Confex – professionals meet in Mumbai
InnoPack Pharma Conference is a big platform for all the pharmaceutical professionals to meet and exchange ideas and knowledge for the future progress of...
Cipla sees a steady growth in various markets
It has been 7 years since Samina Hamied, the niece of YK Hamied, joined the board of Cipla. And during this period, the journey...
US FDA resumes inspections in India
In February 2022, FDA officials stated that the agency is eager to resume inspections, including surprise inspections in India. On Thursday, 10 March 2022,...
Cipla wins Frost & Sullivan and Teri’s Sustainability 4.0 Award 2021
Cipla announced that it has been awarded as a ‘Challenger in Mega Large Business Pharma Sector’ by Frost & Sullivan and Teri’s Sustainability 4.0...
Cipla to launch oral antiviral drug, Cipmolnu in India
Cipla announced that it has been granted Emergency Use Authorisation(EUA) permission by the Drug Controller General of India (DCGI) to launch Molnupiravir in the...